Table 2.
Baseline description of renal cell carcinoma patients with or without lymphovascular.
| Pre-propensity cohort | Post-propensity cohort | |||||
|---|---|---|---|---|---|---|
| LVI (−) | LVI (+) | P value | LVI (−) | LVI (+) | P value | |
| Age (years) | 56 ± 12.6 | 58 ± 12.1 | 0.0885 | 56.5 ± 12.8 | 59.2 ± 11.6 | 0.1064 |
| BMI | 24.6 ± 3.3 | 24.3 ± 3.2 | 0.3293 | 24.6 ± 3.5 | 24.5 ± 3.3 | 0.7841 |
| Sex | 0.7192 | 0.595 | ||||
| Male | 2486 (71.75) | 85 (70.25) | 246 (71.3) | 47 (68.12) | ||
| Female | 979 (28.25) | 36 (29.75) | 99 (28.7) | 22 (31.88) | ||
| DM | 0.8164 | 0.6425 | ||||
| No | 2667 (83.95) | 100 (84.75) | 281 (81.45) | 57 (83.82) | ||
| Yes | 510 (16.05) | 18 (15.25) | 64 (18.55) | 11 (16.18) | ||
| HTN | 0.0903 | 0.1687 | ||||
| No | 1889 (60.03) | 80 (67.8) | 206 (60.23) | 47 (69.12) | ||
| Yes | 1258 (39.97) | 38 (32.2) | 136 (39.77) | 21 (30.88) | ||
| CKD | 0.0871 | 0.2068 | ||||
| No | 2476 (97.56) | 117 (100) | 335 (97.67) | 67 (100) | ||
| Yes | 62 (2.44) | 0 (0) | 8 (2.33) | 0 (0) | ||
| Smoking status | 0.0359 | 0.6264 | ||||
| Non-smoker | 1742 (65.64) | 45 (52.94) | 190 (56.38) | 34 (50) | ||
| Ex-smoker | 377 (14.2) | 19 (22.35) | 70 (20.77) | 16 (23.53) | ||
| Current smoker | 535 (20.16) | 21 (24.71) | 77 (22.85) | 18 (26.47) | ||
| ECOG_index | 0.0027 | 0.8813 | ||||
| 0 | 2299 (72.5) | 89 (87.25) | 286 (84.37) | 59 (86.76) | ||
| 1 | 576 (18.16) | 11 (10.78) | 47 (13.86) | 8 (11.76) | ||
| >=2 | 296 (9.33) | 2 (1.96) | 6 (1.77) | 1 (1.47) | ||
| Fuhrman grade | <0.0001 | 0.4718 | ||||
| 1 & 2 | 2038 (62.21) | 37 (34.58) | 120 (34.78) | 21 (30.43) | ||
| 3 | 1123 (34.28) | 58 (54.21) | 187 (54.2) | 37 (53.62) | ||
| 4 | 115 (3.51) | 12 (11.21) | 38 (11.01) | 11 (15.94) | ||
| Sarcomatoid differentiation | 0.0081 | 0.5178 | ||||
| No | 2358 (98.54) | 71 (94.67) | 331 (95.94) | 65 (94.2) | ||
| Yes | 35 (1.46) | 4 (5.33) | 14 (4.06) | 4 (5.8) | ||
| Tumor size | 33.1 (32.2–34) | 59 (53.7–64.9) | <0.0001 | 58.8 (56.1–61.7) | 58.7 (52.8–65.3) | 0.9812 |
Invasion according to pre- and post-propensity matching.